share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC

SEC announcement ·  Jun 12 04:03
Summary by Futu AI
LILLY ENDOWMENT INC, a reporting entity associated with Eli Lilly and Co (LLY), completed a significant sale of Eli Lilly's common stock on June 10, 2024. The transactions were executed in the open market, with a total of 75,510 shares sold. Prices per share ranged from $851.688 to $870.13, resulting in an aggregate market value of approximately $64,997,274. Following the sales, LILLY ENDOWMENT INC's direct holdings in Eli Lilly amounted to 97,793,810 shares of common stock. The sales occurred in a single day, indicating a substantial change in the endowment's investment in the pharmaceutical company.
LILLY ENDOWMENT INC, a reporting entity associated with Eli Lilly and Co (LLY), completed a significant sale of Eli Lilly's common stock on June 10, 2024. The transactions were executed in the open market, with a total of 75,510 shares sold. Prices per share ranged from $851.688 to $870.13, resulting in an aggregate market value of approximately $64,997,274. Following the sales, LILLY ENDOWMENT INC's direct holdings in Eli Lilly amounted to 97,793,810 shares of common stock. The sales occurred in a single day, indicating a substantial change in the endowment's investment in the pharmaceutical company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.